fbpx

ALK-Abelló A/S

alk

ALK-Abelló A/S is an international pharmaceutical company devoted to improve the lives of people with allergies by developing pharmaceuticals products that target the cause of allergy.

ALK-Abelló A/S is the world leader in allergy vaccination (immunotherapy) – a unique treatment including a protective immune response that reduces and potentially halts the allergic reaction.

For further information: www.alk.net

Lundbeckfonden

News

Surge in new alcohol genes
2. June 2020
Video: Meet five professors who have devoted their brains to helping ours
14. May 2020
300 post-mortems are the cornerstone of a new Danish coronavirus project
8. May 2020